GLP-1s appear to protect against cancer. Researchers are trying to figure out how
Recent studies suggest that GLP-1 drugs, used for diabetes, obesity, and sleep apnea, may reduce the risk of several cancers and slow their progression. These medications appear to lower cancer risk across multiple types, including breast, liver, and colorectal cancers, even in those not directly linked to obesity. Researchers are now investigating how these drugs might work beyond weight loss, possibly through metabolic and anti-inflammatory effects. The findings are based on observational data and early-stage research, prompting further exploration into their potential role in cancer prevention.
New studies suggest GLP-1 drugs, used for diabetes and obesity, may lower cancer risk and slow cancer progression.
These findings could lead to new ways of preventing or treating cancer, especially as GLP-1s are already widely used for other conditions.
This story highlights how existing medications might have unexpected health benefits, offering hope for more effective, accessible treatments.
upbeatBytes summarizes in its own words and links to the original publisher — it doesn't host the article.